Logo image of XRAY

DENTSPLY SIRONA INC (XRAY) Stock Price, Quote, News and Overview

NASDAQ:XRAY - Nasdaq - US24906P1093 - Common Stock - Currency: USD

19.44  +0.08 (+0.41%)

After market: 19.44 0 (0%)

XRAY Quote, Performance and Key Statistics

DENTSPLY SIRONA INC

NASDAQ:XRAY (1/23/2025, 8:34:09 PM)

After market: 19.44 0 (0%)

19.44

+0.08 (+0.41%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
Statistics
52 Week High35.47
52 Week Low17.21
Market Cap3.86B
Shares198.78M
Float197.95M
Yearly Dividend0.55
Dividend Yield3.47%
PE10.51
Fwd PE9.88
Earnings (Next)N/A N/A
IPO08-12 1987-08-12


XRAY short term performance overview.The bars show the price performance of XRAY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20

XRAY long term performance overview.The bars show the price performance of XRAY in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of XRAY is 19.44 USD. In the past month the price increased by 3.96%. In the past year, price decreased by -44.33%.

DENTSPLY SIRONA INC / XRAY Daily stock chart

XRAY Latest News, Press Releases and Analysis

News Image
8 hours ago - Faruqi & Faruqi, LLP

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DENTSPLY SIRONA Inc. ("Dentsply" or the...

News Image
17 hours ago - The Gross Law Firm

Dentsply Sirona Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before January 27, 2025 to Discuss Your Rights - XRAY

/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY). Shareholders who purchased shares of...

News Image
a day ago - Kessler Topaz Meltzer & Check, LLP

XRAY DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in DENTSPLY SIRONA Inc. (XRAY) Securities Fraud Class Action Lawsuit

/PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed...

News Image
2 days ago - TheNewswire.com

XRAY Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds DENTSPLY SIRONA Inc. (XRAY) Investors of Filing Deadline in Class Action Lawsuit

RADNOR, PA - January 22, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that securities class action lawsuits have been filed against DENTSPLY SIRONA Inc. (“DENTSPLY”) (NASDAQ: XRAY) on behalf of those who purchased or otherwise acquired DENTSPLY common stock between May 6, 2021, and November 6, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 27, 2025.

XRAY Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ALC ALCON INC 29.51 44.53B
COO COOPER COS INC/THE 25.86 19.10B
ALGN ALIGN TECHNOLOGY INC 25.2 17.53B
SOLV SOLVENTUM CORP 17.69 12.72B
LNTH LANTHEUS HOLDINGS INC 14.07 6.79B
MMSI MERIT MEDICAL SYSTEMS INC 30.85 6.04B
BLCO BAUSCH + LOMB CORP 27.62 5.93B
ICUI ICU MEDICAL INC 29.42 4.09B
HAE HAEMONETICS CORP/MASS 17.86 3.66B
NEOG NEOGEN CORP 29.35 2.54B
UFPT UFP TECHNOLOGIES INC 37.45 2.01B
RXST RXSIGHT INC N/A 1.31B

About XRAY

Company Profile

XRAY logo image Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in York, Pennsylvania and currently employs 15,000 full-time employees. The company develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.

Company Info

DENTSPLY SIRONA INC

Suite 60W, 221 West Philadelphia Street

York PENNSYLVANIA 28277 US

CEO: Donald M. Casey

Employees: 15000

Company Website: https://www.dentsplysirona.com/

Investor Relations: https://investor.dentsplysirona.com

Phone: 18445463722

XRAY FAQ

What is the price of XRAY?

The current price of XRAY is 19.44 USD.


What is the symbol for DENTSPLY SIRONA INC?

The exchange symbol of DENTSPLY SIRONA INC is XRAY and it is listed on the Nasdaq exchange.


On which exchange is XRAY listed?

XRAY is listed on the Nasdaq exchange.


Is XRAY a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for XRAY, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of XRAY.


Does XRAY pay dividends?

XRAY has a dividend yield of 3.47%. The yearly dividend amount is currently 0.55.


What is the Price/Earnings (PE) ratio of XRAY?

The PE ratio for XRAY is 10.51. This is based on the reported non-GAAP earnings per share of 1.85 and the current share price of 19.44 USD.


What is the Short Interest ratio of XRAY?

The outstanding short interest for XRAY is 4.97% of its float.


XRAY Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to XRAY. When comparing the yearly performance of all stocks, XRAY is a bad performer in the overall market: 91.3% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

XRAY Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to XRAY. XRAY has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

XRAY Financial Highlights

Over the last trailing twelve months XRAY reported a non-GAAP Earnings per Share(EPS) of 1.85. The EPS increased by 0% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -6.23%
ROE -16.58%
Debt/Equity 0.72
Chartmill High Growth Momentum
EPS Q2Q%2.04%
Sales Q2Q%0.42%
EPS 1Y (TTM)0%
Revenue 1Y (TTM)-0.91%

XRAY Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 75% to XRAY. The Buy consensus is the average rating of analysts ratings from 22 analysts.

For the next year, analysts expect an EPS growth of 2.38% and a revenue growth -2.9% for XRAY


Ownership
Inst Owners108.57%
Ins Owners0.25%
Short Float %4.97%
Short Ratio2.7
Analysts
Analysts75.45
Price Target23.62 (21.5%)
EPS Next Y2.38%
Revenue Next Year-2.9%